[1] 马晓明.胃肠道间质瘤临床病理免疫组化研究[J].现代医药
卫生,2011,27(1):50-51.
[2] Logrono R,Jones DV,Faruqi S,et al. Recent advances in
cell biology, diagnosis, and therapy of gastrointestinal stromal
tumor(GIST)[J].CancerBiolTher,2004,3(3):251-258.
[3] 温建成,黄小萍,苏少雪,等.18例胃肠道间质瘤临床病理研
究及免疫组化分析[J].基层医学理论,2006,10(4):
291-293.
[4] 沈道清,唐承刚.胃间质瘤患者病理及免疫组化分析研究[J].
当代医学,2012,18(2):70.
[5] Miettinen M, Lasota J. Gastrointestinal stromal tumors-defi?
nition, clinical, histological, immunohistochemical, and mo?
lecular genetic features and differential diagnosis [J].Vir?
chows Arch,2001,438(1):1-12.
[6] Rosai J. GIST:an update[J].Int J Surg Pathol,2003,11(3):
177-86.
[7] 王彦丽,赵向荣,白辰光,等.胃肠道间质瘤组织中PDGFRα和
C-kit基因突变和蛋白表达的关系[J].世界华人消化杂志,
2007,15(8):2300-2305.
[8] Lin SC,Huang MJ,Zeng CY,et al. Clinical manifestations
and prognostic factors in patients with gastrointestinal stromal
tumors[J].World J Gastroenterol,2003,9(12):2809-2812.
[9] 候英勇,朱雄增.胃肠道间质瘤临床病理研究进展[J].实用肿
瘤志,2003,18(4):257-259.